PURPOSE OF REVIEW: This review updates recent findings about Escherichia coli O157:H7 virulence factors and its bovine reservoir. This Shiga toxin (Stx)-producing E. coli belongs to the Enterohemorrhagic E. coli (EHEC) pathotype causing hemorrhagic colitis. Its low infectious dose makes it an efficient, severe, foodborne pathogen. Although EHEC remains in the intestine, Stx can translocate systemically and is cytotoxic to microvascular endothelial cells, especially in the kidney and brain. Disease can progress to life-threatening hemolytic uremic syndrome (HUS) with hemolytic anemia, acute kidney failure, and thrombocytopenia. Young children, the immunocompromised, and the elderly are at the highest risk for HUS. Healthy ruminants are the major reservoir of EHEC and cattle are the primary source of human exposure. RECENT FINDINGS: Advances in understanding E. coli O157:H7 pathogenesis include molecular mechanisms of virulence, bacterial adherence, type three secretion effectors, intestinal microbiome, inflammation, and reservoir maintenance. SUMMARY: Many aspects of E. coli O157:H7 disease remain unclear and include the role of the human and bovine intestinal microbiomes in infection. Therapeutic strategies involve controlling inflammatory responses and/or intestinal barrier function. Finally, elimination/reduction of E. coli O157:H7 in cattle using CRISPR-engineered conjugative bacterial plasmids and/or on-farm management likely hold solutions to reduce infections and increase food safety/security.
PURPOSE OF REVIEW: This review updates recent findings about Escherichia coli O157:H7 virulence factors and its bovine reservoir. This Shiga toxin (Stx)-producing E. coli belongs to the Enterohemorrhagic E. coli (EHEC) pathotype causing hemorrhagic colitis. Its low infectious dose makes it an efficient, severe, foodborne pathogen. Although EHEC remains in the intestine, Stx can translocate systemically and is cytotoxic to microvascular endothelial cells, especially in the kidney and brain. Disease can progress to life-threatening hemolytic uremic syndrome (HUS) with hemolytic anemia, acute kidney failure, and thrombocytopenia. Young children, the immunocompromised, and the elderly are at the highest risk for HUS. Healthy ruminants are the major reservoir of EHEC and cattle are the primary source of human exposure. RECENT FINDINGS: Advances in understanding E. coli O157:H7 pathogenesis include molecular mechanisms of virulence, bacterial adherence, type three secretion effectors, intestinal microbiome, inflammation, and reservoir maintenance. SUMMARY: Many aspects of E. coli O157:H7 disease remain unclear and include the role of the human and bovine intestinal microbiomes in infection. Therapeutic strategies involve controlling inflammatory responses and/or intestinal barrier function. Finally, elimination/reduction of E. coli O157:H7 in cattle using CRISPR-engineered conjugative bacterial plasmids and/or on-farm management likely hold solutions to reduce infections and increase food safety/security.
Authors: Maria A Ledesma; Sara A Ochoa; Ariadnna Cruz; Luz M Rocha-Ramírez; Jaime Mas-Oliva; Carlos A Eslava; Jorge A Girón; Juan Xicohtencatl-Cortes Journal: PLoS One Date: 2010-08-12 Impact factor: 3.240
Authors: Ana Arbeloa; Richard R Bulgin; Georgina MacKenzie; Robert K Shaw; Mark J Pallen; Valerie F Crepin; Cedric N Berger; Gad Frankel Journal: Cell Microbiol Date: 2008-03-05 Impact factor: 3.715
Authors: Andrea Hodgson; Eric M Wier; Kai Fu; Xin Sun; Hongbing Yu; Wenxin Zheng; Ho Pan Sham; Kaitlin Johnson; Scott Bailey; Bruce A Vallance; Fengyi Wan Journal: PLoS Pathog Date: 2015-03-10 Impact factor: 6.823
Authors: Alline R Pacheco; Jacob E Lazarus; Brandon Sit; Stefanie Schmieder; Wayne I Lencer; Carlos J Blondel; John G Doench; Brigid M Davis; Matthew K Waldor Journal: mBio Date: 2018-06-19 Impact factor: 7.867